1. Home
  2. ELME vs ELDN Comparison

ELME vs ELDN Comparison

Compare ELME & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elme Communities

ELME

Elme Communities

HOLD

Current Price

$2.04

Market Cap

198.2M

Sector

Real Estate

ML Signal

HOLD

Logo Eledon Pharmaceuticals Inc.

ELDN

Eledon Pharmaceuticals Inc.

HOLD

Current Price

$3.09

Market Cap

229.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELME
ELDN
Founded
1960
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
198.2M
229.3M
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
ELME
ELDN
Price
$2.04
$3.09
Analyst Decision
Hold
Strong Buy
Analyst Count
3
2
Target Price
$12.67
$8.50
AVG Volume (30 Days)
1.4M
1.3M
Earning Date
04-30-2026
05-13-2026
Dividend Yield
741.95%
N/A
EPS Growth
N/A
30.67
EPS
N/A
N/A
Revenue
$206,360,000.00
N/A
Revenue This Year
$5.03
N/A
Revenue Next Year
$4.31
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.98
$1.35
52 Week High
$17.68
$4.60

Technical Indicators

Market Signals
Indicator
ELME
ELDN
Relative Strength Index (RSI) 23.19 60.69
Support Level $1.98 $2.48
Resistance Level $2.26 $3.17
Average True Range (ATR) 0.05 0.22
MACD 0.08 -0.00
Stochastic Oscillator 29.63 70.83

Price Performance

Historical Comparison
ELME
ELDN

About ELME Elme Communities

Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located near transportation nodes. Washington REIT derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Washington REIT's tenants are banking, consulting, law, and financial services firms.

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

Share on Social Networks: